跳至主要内容
临床试验/NCT00159107
NCT00159107已完成4 期

Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents

Heinrich-Heine University, Duesseldorf1 个研究点 分布在 1 个国家目标入组 371 人开始时间: 2003年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
371
试验地点
1
主要终点
Abstinence

研究概览

简要总结

The main aim of this project consists in the investigation of the interaction of behavior therapy and Acamprosate in the outpatient treatment of alcoholic patients in a randomized, prospective and (regarding study medication Acamprosate vs. Placebo) double blind design. A total of 371 patients has been randomly assigned immediately after detoxification to one of three different outpatient treat-ment conditions.

详细描述

The objective of this multi-center study is to optimize the long-term treatment of patients with alcohol dependence. This investigation should contribute to the issue of effective relapse prevention. Each treatment condition is lasting 6 months: a) Behavior Group Therapy + Acamprosate, b) Behavior Group Therapy + Placebo and c) support and counseling + Acamprosate. Follow-up examinations carried out 3 and 6 months after the end of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • DSMIV criteria of alcoholism
  • Age between 25 and 60
  • Informed consent

排除标准

  • Residence outside of the catchment area
  • Legal reasons
  • Insufficient knowledge of the German language
  • Substance abuse or addiction other than alcohol or nicotine
  • Pregnancy
  • Serious physical illness
  • Organic brain disease
  • Contraindication to Acamprosate treatment

研究组 & 干预措施

2

Experimental

Placebo +Integrative behavior therapy

干预措施: Integrative behavior therapy (Behavioral)

2

Experimental

Placebo +Integrative behavior therapy

干预措施: Placebo (Drug)

3

Experimental

Acamprosate + treatment as usual

干预措施: Acamprosate (Drug)

1

Experimental

Acamprosate + Integrative behavior therapy

干预措施: Acamprosate (Drug)

1

Experimental

Acamprosate + Integrative behavior therapy

干预措施: Integrative behavior therapy (Behavioral)

结局指标

主要结局

Abstinence

时间窗: 3,6,12 months

次要结局

  • Social functioning(12 months)
  • Cognitive functioning(12 months)

研究者

发起方
Heinrich-Heine University, Duesseldorf
申办方类型
Other

研究点 (1)

Loading locations...

相似试验